Nasal Decongestant Spray Recalled for Contaminated Excipient
Perrigo Company is recalling NASAL oxymetazoline HCl nasal spray nationwide due to contaminated excipient used in manufacturing. The affected product was distributed to retailers including Kroger.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a manufacturing contamination issue. The source text does not report any illnesses, injuries, or adverse events; the recall is based on a CGMP deviation (use of a recalled excipient). Under the rubric, contamination without reported harm and no Class I designation typically scores 2 (Moderate).
Plain-English summary
Perrigo Company PLC is recalling NASAL brand nasal spray decongestant (oxymetazoline HCl 0.05%, 1 FL Oz bottles) due to current good manufacturing practice (CGMP) deviations. The product was manufactured with a contaminated excipient that had itself been recalled by the excipient supplier.
Approximately 7,632 bottles were affected, batch 1BK0826 with expiration date 12/31/2022. The product was distributed nationwide in the USA and distributed through The Kroger Co.
Consumers who have purchased this product should stop using it. Individuals with questions or concerns should consult their healthcare provider or pharmacist.
The recalled product
- Product
- NASAL (OXYMETAZOLINE HCL)
- Brand
- NASAL
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — OTC Nasal Decongestant
- Hazard
- contaminated-excipient
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 1BK0826
- Exp 12/31/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · NASAL
- ModeratePerrigo Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateNasal Oxymetazoline Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateOxymetazoline Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModeratePerrigo Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModeratePerrigo Nasal Oxymetazoline Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27